Hong Kong-based Maytree Asset Management has established a significant new position in semiconductor substrate maker AXT, Inc., a move that highlights investor confidence in the materials underpinning the AI boom, even as questions about valuation linger.
While Merck (MSD) delivered robust fourth-quarter results, its forecast for 2026 fell below Wall Street expectations, highlighting investor anxiety over impending patent expiries for blockbuster drugs like Keytruda.
ARK Invest's latest purchase of Joby shares highlights a deep conviction in urban air mobility, but analysts warn the stock's sky-high valuation leaves no room for error on the path to FAA certification and commercial scale.
Despite a stellar year-to-date performance fueled by promising clinical trial results, analyst sentiment on Moderna remains tempered, with a consensus 'Hold' rating highlighting the challenges beyond its COVID-19 windfall.
At its 2026 Annual Meeting, Emerson Electric shareholders reelected three directors and approved executive pay and auditor selection, but a key governance proposal to declassify the board failed to secure the required supermajority vote.
Capital Southwest (CSWC) reported strong fiscal third-quarter results, driven by recurring portfolio earnings and active deal-making. The BDC highlighted a growing cash cushion, declared supplemental dividends, and unveiled a strategic joint venture to compete in a tighter spread environment.
The dialysis provider's robust quarterly results and raised guidance signal a potential turnaround, challenging last year's bearish narrative and sending its stock sharply higher.
Sartorius reports a return to 'normal' demand for consumables in its preliminary 2025 results, driving sales past €3.5 billion. While equipment investment remains subdued, strong recurring revenue and cost discipline fueled profit growth, setting a cautiously optimistic tone for 2026.
In a strategic shift, PepsiCo announces price reductions for popular snacks like Doritos and Cheetos in the U.S., responding to consumer backlash over high costs and adapting to market changes driven by weight-loss drugs.
Furniture maker Flexsteel Industries reports a 9% year-over-year sales increase for its fiscal second quarter, driven by strategic pricing and new product launches. However, executives caution that looming 25% tariffs on inventory and a volatile consumer environment pose significant challenges for the latter half of 2026.
The e-commerce giant has agreed to a major settlement to resolve class action claims that its automated returns system wrongly withheld refunds from U.S. customers, marking another significant regulatory payout for the company.
As major miners retreat amid volatile markets, stablecoin giant Tether launches an ambitious software suite aimed at industrializing and streamlining Bitcoin mining operations worldwide.
President Trump signals openness for China and India to purchase Venezuelan crude, marking a potential shift in U.S. sanctions policy and global oil flows, with strategic implications for asphalt supply chains and geopolitical alliances.
Despite a challenging economic landscape marked by tariff pressures and soft MRO demand, W.W. Grainger reported resilient 2025 results, achieving 4.9% organic sales growth and strategic progress. The industrial supplies leader is doubling down on technology, supply chain expansion, and customer experience to drive market share gains in the coming year.
Marathon Petroleum Corporation (MPC) reported robust full-year 2025 financial performance, driven by strong refining margins and operational execution. The company highlighted a disciplined capital strategy, strategic midstream growth, and a positive outlook for refined product demand into 2026.
A wave of selling pressure hit the software sector Wednesday morning, dragging down shares of prominent firms like Five9, Rapid7, and SentinelOne. The downturn reflects a broader market pivot as investors reassess traditional SaaS models in favor of businesses with deeply integrated artificial intelligence capabilities.
French prosecutors have called on an appeals court to confirm a five-year ban on far-right leader Marine Le Pen holding public office, a move that could definitively bar her from the 2027 presidential race. The legal battle centers on fraud allegations involving European Parliament funds.
U.S. Attorney Jeanine Pirro faces intense backlash from Republican lawmakers and gun rights advocates after stating in a televised interview that anyone bringing a firearm into Washington, D.C. would face jail time, forcing a rare public rift among conservatives on gun policy.
As companies grapple with bloated software portfolios, a push for Go-To-Market platform consolidation is gaining momentum. Beyond cost savings, executives are finding that a unified system is critical for data integrity, sales velocity, and strategic agility in a competitive market.
Analysts at Clear Street have increased their price target for Wave Life Sciences to $50, maintaining a Buy rating. The move follows GSK's decision to return rights to the alpha-1 antitrypsin deficiency candidate WVE-006, which the firm views favorably despite a muted market reaction.
